Medicis (MRX) Shares Showing Resilience Despite FDA Letter for LIPOSONIX
Tweet Send to a Friend
Shares of Medicis (NYSE: MRX) are making their way back up towards positive territory, despite the recent letter from the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


